Patents by Inventor Eric Leslie Bell
Eric Leslie Bell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11771658Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, ethylenediaminedisuccinic acid, an oxidant, water, and optionally citric acid, is provided along with temperature conditions to directly form within the reaction mixture, a stable dispersion of cerium oxide nanoparticles. Biocompatible nanoparticles comprised of cerium oxide, ethylenediaminedisuccinic acid, and optionally citric acid, are described. An increase in catalase-like enzyme activity is demonstrated by cerium oxide nanoparticles prepared with citric acid and ethylenediaminedisuccinic acid.Type: GrantFiled: December 9, 2021Date of Patent: October 3, 2023Assignee: Cerion, LLCInventor: Eric Leslie Bell
-
Publication number: 20220096392Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, ethylenediaminedisuccinic acid, an oxidant, water, and optionally citric acid, is provided along with temperature conditions to directly form within the reaction mixture, a stable dispersion of cerium oxide nanoparticles. Biocompatible nanoparticles comprised of cerium oxide, ethylenediaminedisuccinic acid, and optionally citric acid, are described. An increase in catalase-like enzyme activity is demonstrated by cerium oxide nanoparticles prepared with citric acid and ethylenediaminedisuccinic acid.Type: ApplicationFiled: December 9, 2021Publication date: March 31, 2022Applicant: Cerion, LLCInventor: Eric Leslie Bell
-
Publication number: 20200345650Abstract: A process for making nanoparticles of biocompatible materials, wherein an aqueous reaction mixture comprising cerous ion, ethylenediaminedisuccinic acid, an oxidant, water, and optionally citric acid, is provided along with temperature conditions to directly form within the reaction mixture, a stable dispersion of cerium oxide nanoparticles. Also, biocompatibe nanoparticles comprised of cerium oxide, ethyenediaminedisuccinic acid, and optionally citric acid. An increase in catalase-like enzyme activity is demonstrated by cerium oxide nanoparticles prepared with citric acid and ethylenediaminedisuccinic acid.Type: ApplicationFiled: May 28, 2020Publication date: November 5, 2020Applicant: Cerion, LLCInventor: Eric Leslie Bell
-
Patent number: 10729717Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury.Type: GrantFiled: May 7, 2018Date of Patent: August 4, 2020Assignee: Cerion Enterprises LLCInventors: Kenneth Joseph Reed, Wendi Ann Costanzo, Joseph Samuel Erlichman, Eric Leslie Bell
-
Patent number: 10722474Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, ethylenediaminedisuccinic acid, an oxidant, water, and optionally citric acid, is provided along with temperature conditions to directly form within the reaction mixture, a stable dispersion of cerium oxide nanoparticles. Biocompatible, nanoparticles comprised of cerium oxide, ethylenediaminedisuccinic acid, and optionally citric acid, are described. An increase in catalase-like enzyme activity is demonstrated by cerium oxide nanoparticles prepared with citric acid and ethylenediaminedisuccinic acid.Type: GrantFiled: January 20, 2016Date of Patent: July 28, 2020Assignee: Cerion, LLCInventor: Eric Leslie Bell
-
Publication number: 20180325832Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, ethylenediaminedisuccinic acid, an oxidant, water, and optionally citric acid, is provided along with temperature conditions to directly form within the reaction mixture, a stable dispersion of cerium oxide nanoparticles. Biocompatible, nanoparticles comprised of cerium oxide, ethylenediaminedisuccinic acid, and optionally citric acid, are described. An increase in catalase-like enzyme activity is demonstrated by cerium oxide nanoparticles prepared with citric acid and ethylenediaminedisuccinic acid.Type: ApplicationFiled: January 20, 2016Publication date: November 15, 2018Applicant: Cerion, LLCInventor: Eric Leslie Bell
-
Publication number: 20180250333Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury.Type: ApplicationFiled: May 7, 2018Publication date: September 6, 2018Applicant: CERION, LLCInventors: Kenneth Joseph Reed, Wendi Ann Costanzo, Joseph Samuel Erlichman, Eric Leslie Bell
-
Patent number: 9962406Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury.Type: GrantFiled: December 22, 2016Date of Patent: May 8, 2018Assignee: CERION, LLCInventors: Kenneth Joseph Reed, Wendi Ann Costanzo, Joseph Samuel Erlichman, Eric Leslie Bell
-
Publication number: 20170100430Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury.Type: ApplicationFiled: December 22, 2016Publication date: April 13, 2017Applicant: CERION, LLCInventors: KENNETH JOSEPH REED, WENDI ANN COSTANZO, JOSEPH SAMUEL ERLICHMAN, ERIC LESLIE BELL
-
Patent number: 9533007Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury.Type: GrantFiled: April 20, 2015Date of Patent: January 3, 2017Assignee: CERION, LLCInventors: Kenneth Joseph Reed, Wendi Ann Costanzo, Joseph Samuel Erlichman, Eric Leslie Bell
-
Publication number: 20150231174Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury.Type: ApplicationFiled: April 20, 2015Publication date: August 20, 2015Applicant: CERION, LLCInventors: Kenneth Joseph Reed, Wendi Ann Costanzo, Joseph Samuel Erlichman, Eric Leslie Bell
-
Patent number: 9034392Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury.Type: GrantFiled: March 15, 2013Date of Patent: May 19, 2015Assignee: CERION, LLCInventors: Kenneth Joseph Reed, Wendi Ann Costanzo, Joseph Samuel Erlichman, Eric Leslie Bell
-
Publication number: 20130337083Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury.Type: ApplicationFiled: March 15, 2013Publication date: December 19, 2013Applicant: Cerion Enterprises, LLCInventors: Kenneth Joseph Reed, Wendi Ann Costanzo, Joseph Samuel Erlichman, Eric Leslie Bell
-
Patent number: 5792601Abstract: A radiation sensitive emulsion is disclosed containing iridium doped composite silver halide grains comprised of (a) host portions having an average aspect ratio of less than 1.3 and consisting essentially of monodisperse silver iodochloride grains containing from 0.05 to 3 mole percent iodide, based on total silver forming the host portions, with maximum iodide concentrations located nearer the surface of the host portions than their center and (b) epitaxially deposited portions containing the iridium dopant and silver bromide accounting for from 0.1 to 5 mole percent of total silver forming the composite grains.The emulsions are prepared by (a) first providing an emulsion containing grains which form the host portions of the grains and (b) modifying the performance properties of the host grains by a combination of silver bromide addition, iridium dopant incorporation and antifoggant addition, in which, prior to antifoggant addition, silver bromide in the amount of from 0.1 to 5.Type: GrantFiled: July 29, 1996Date of Patent: August 11, 1998Assignee: Eastman Kodak CompanyInventors: James Lawrence Edwards, Benjamin Teh-Kung Chen, Eric Leslie Bell, Roger Lok